Hotgen

About:

Hotgen is a diagnostic technology platform that develops liquid biopsy early screening technology.

Website: http://www.hotgen.com.cn/

Twitter/X: gracehotgen

Top Investors: Fortune Venture Capital, ShenZhen GTJA Investment Group, Greenriver Investment

Description:

Hotgen engages in research, develops, and manufactures medical and public safety inspection products. It is a diagnostic technology platform that develops and expands liquid biopsy early screening technology for cancer and establishes a multi-omics diagnostic technology platform including protein markers, sugar chain exosomes, and DNA methylation. Their technology deploys antibody drugs, live bacteria drugs, exosome drugs, and other biopharmaceutical fields and creates a development strategy for the entire industry chain, from diagnosis to treatment.

Total Funding Amount:

33M CNY

Headquarters Location:

Daxing, Beijing, China

Founded Date:

2005-06-23

Contact Email:

hotgen(AT)hotgen.com.cn

Founders:

Number of Employees:

1001-5000

Last Funding Date:

2019-01-11

IPO Status:

Public

Industries:

© 2025 bioDAO.ai